WebDisclosure WebDisclosure
Basculer en Français
10816 Companies
234354 Keywords
163137 Articles
125319 Press releases
Headlines Articles Press releases Generate:Biomedicines Remove
  1. Home
  2. Companies
  3. Generate:Biomedicines
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/01/2025 at 12:10, 8 months 8 days ago

    Generate:Biomedicines Initiates Phase 3 Trials for Asthma Antibody GB-0895

    Phase 3 Trials Generate:Biomedicines GB-0895 Asthma Treatment AI Engineered Antibody
  • BRIEF

    published on 12/01/2025 at 12:10, 8 months 8 days ago

    Generate:Biomedicines lance des essais de phase 3 pour l'anticorps contre l'asthme GB-0895

    Essais De Phase 3 GB-0895 Générer : Biomédicaments Traitement De L'asthme Anticorps Conçu Par IA
  • PRESS RELEASE

    published on 12/01/2025 at 12:05, 8 months 9 days ago

    Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

    Generate:Biomedicines to initiate global Phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI. SOLAIRIA-1 and SOLAIRIA-2 will evaluate efficacy in reducing asthma exacerbations, reflecting commitment to developing innovative therapies
    AI Engineering Phase 3 Studies Generate:Biomedicines GB-0895 Severe Asthma
    Logo of Generate:Biomedicines
Accesswire
  • Published on 08/10/2026 at 11:00, 1 hour 8 minutes ago

    Blue Lagoon Announces C$10 Million Strategic Investment by Nicola Mining and Ocean Partners

  • Published on 08/10/2026 at 08:00, 4 hours 8 minutes ago

    Galantas Gold Expands Indiana Drill Program to 12,500 Metres

  • Published on 08/10/2026 at 08:00, 4 hours 8 minutes ago

    Results of AGM and Management Update Presentation

  • Published on 08/08/2026 at 00:00, 2 days 12 hours ago

    Boron One Announces Change of Auditor

  • Published on 08/07/2026 at 23:15, 2 days 12 hours ago

    Faraday Copper Reports Second Quarter 2026 Financial Results

View all ACCESSWIRE
EQS Group
  • Published on 08/10/2026 at 11:35, 33 minutes ago

    SOLIZE PARTNERS and Dassault Systèmes Form Partnership to Accelerate Digital Transformation in Manufacturing

  • Published on 08/10/2026 at 11:28, 40 minutes ago

    Aroundtown SA: Release of a capital market information

  • Published on 08/10/2026 at 10:43, 1 hour 24 minutes ago

    RM plc: Holding(s) in Company

  • Published on 08/10/2026 at 10:12, 1 hour 56 minutes ago

    Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

  • Published on 08/10/2026 at 10:10, 1 hour 58 minutes ago

    Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea

View all EQS
Les Echos
  • Published on 08/10/2026 at 11:53, 15 minutes ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

  • Published on 08/10/2026 at 11:53, 15 minutes ago

    GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026

  • Published on 08/10/2026 at 11:36, 32 minutes ago

    GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

  • Published on 08/10/2026 at 11:36, 32 minutes ago

    GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 3 au 7 août 2026

  • Published on 08/10/2026 at 09:47, 2 hours 21 minutes ago

    260810 BENETEAU Transactions sur actions propres

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy